// App-Quantinova.ai

1239 : Outcome of Patients with Chronic Myeloid Leukemia in Lymphoid Blast Crisis (CML-LBC) and Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) Treated with Hyper-CVAD and Dasatinib

Researchers

Presenter

  • Kiyomi Morita

Principal Investigators

  • Hagop M. Kantarjian

  • Farhad Ravandi

  • Koji Sasaki

  • Nitin Jain

  • Marina Konopleva

  • Nicholas J. Short

  • Koichi Takahashi

  • Rita Khouri

  • Patrice Nasnas

  • Courtney D. DiNardo

  • Tapan M. Kadia

  • Guillermo Garcia-Manero

  • Naval Daver

  • Guillermo Montalban Bravo

  • Ghayas C. Issa

  • Jorge E. Cortes

  • Elias Jabbour

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Georgia Cancer Center, Augusta University, Augusta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Hypercarotenemia and vitamin A deficiency

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 206

Drug/Treatment

  • Methotrexate

  • Vincristine

  • Cytarabine liposomal

  • Rituximab

  • dasatinib

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved